Monte Rosa Therapeutics(GLUE)

盘后5.660.000.00%16:00 EST

5.66-0.10-1.82%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Monte Rosa Therapeutics, Inc.盘中异动急速跳水5.29%报5.91美元
  市场透视 · 01-16 22:48
  Monte Rosa Therapeutics, Inc.盘中异动急速跳水5.29%报5.91美元
- Monte Rosa Therapeutics, Inc.盘中异动急速拉升8.45%报6.03美元
  市场透视 · 01-15 22:31
  Monte Rosa Therapeutics, Inc.盘中异动急速拉升8.45%报6.03美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘急速拉升5.48%报5.97美元
  市场透视 · 01-14
  Monte Rosa Therapeutics, Inc.盘中异动早盘急速拉升5.48%报5.97美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘大幅跳水5.00%报5.42美元
  市场透视 · 01-13
  Monte Rosa Therapeutics, Inc.盘中异动早盘大幅跳水5.00%报5.42美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘快速下挫5.09%
  市场透视 · 01-10
  Monte Rosa Therapeutics, Inc.盘中异动早盘快速下挫5.09%
- Monte Rosa Therapeutics, Inc.盘中异动早盘大幅下挫5.13%
  市场透视 · 01-08
  Monte Rosa Therapeutics, Inc.盘中异动早盘大幅下挫5.13%
- Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.08%
  市场透视 · 01-07
  Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.08%
- Monte Rosa Therapeutics, Inc.盘中异动股价大涨5.40%
  市场透视 · 01-03
  Monte Rosa Therapeutics, Inc.盘中异动股价大涨5.40%
- Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.10%
  市场透视 · 2024-12-31
  Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.10%
- Monte Rosa Therapeutics, Inc.盘中异动急速拉升5.22%报6.85美元
  市场透视 · 2024-12-20
  Monte Rosa Therapeutics, Inc.盘中异动急速拉升5.22%报6.85美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘大幅下跌5.22%报7.27美元
  市场透视 · 2024-12-19
  Monte Rosa Therapeutics, Inc.盘中异动早盘大幅下跌5.22%报7.27美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.12%
  市场透视 · 2024-12-13
  Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.12%
- Monte Rosa Therapeutics, Inc.盘中异动急速下挫5.24%报8.95美元
  市场透视 · 2024-12-11
  Monte Rosa Therapeutics, Inc.盘中异动急速下挫5.24%报8.95美元
- Monte Rosa Therapeutics, Inc.盘中异动快速上涨5.42%
  市场透视 · 2024-12-10
  Monte Rosa Therapeutics, Inc.盘中异动快速上涨5.42%
- Monte Rosa Therapeutics, Inc.盘中异动急速拉升5.31%报9.30美元
  市场透视 · 2024-12-06
  Monte Rosa Therapeutics, Inc.盘中异动急速拉升5.31%报9.30美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘大幅跳水5.48%
  市场透视 · 2024-12-04
  Monte Rosa Therapeutics, Inc.盘中异动早盘大幅跳水5.48%
- Monte Rosa Therapeutics, Inc.盘中异动早盘快速拉升5.38%报9.60美元
  市场透视 · 2024-11-29
  Monte Rosa Therapeutics, Inc.盘中异动早盘快速拉升5.38%报9.60美元
- Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.47%报9.07美元
  市场透视 · 2024-11-27
  Monte Rosa Therapeutics, Inc.盘中异动早盘股价大涨5.47%报9.07美元
- Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.01%
  市场透视 · 2024-11-26
  Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.01%
- Monte Rosa Therapeutics, Inc.盘中异动早盘急速上涨5.42%报8.95美元
  市场透视 · 2024-11-25
  Monte Rosa Therapeutics, Inc.盘中异动早盘急速上涨5.42%报8.95美元
公司概况
公司名称
Monte Rosa Therapeutics
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.monterosatx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Monte Rosa Therapeutics, Inc.于2019年11月在特拉华州注册成立。该公司是一家生物制药公司，开发一系列新型小分子精准药物，利用人体的自然机制选择性降解治疗相关的蛋白质。该公司开发了一种名为QuEEN的专有蛋白质降解平台，能够快速识别蛋白质靶标和分子胶降解剂(MGD)，这些候选产品旨在以高度选择性的方式消除治疗相关的蛋白质。该公司相信，小分子MGD可能比现有的治疗方式具有显著优势，因为该公司允许靶向被认为无法成药或药物不足的蛋白质。该公司专注于以强大的生物学和遗传学原理为后盾的治疗目标，目标是发现和开发新型精准药物。这些机会包括肿瘤学和非肿瘤学适应症，包括免疫学、炎症、神经和遗传疾病。
- 01-10
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-12-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-12-05
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-07
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-10-30
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-10-29
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2024-10-28
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-24
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-08-12
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-08-12
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-08-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-08-08
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-06-27
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-06-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report